Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PGE-M
Cat. No.:
OB0425LY-352
Appearance:
Liquid
Purity:
≥98.0%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
PGE-M is a biomarker associated with obesity, smoking and lung metastases with breast cancer.
Synonyms:
Tetranor-PGEM; 24769-56-0; 8-[(1R,2R,5R)-2-(2-Carboxyethyl)-5-hydroxy-3-oxocyclopentyl]-6-oxooctanoic acid; 11R-Hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic acid
CAS No.:
24769-56-0
Compound CID:
161468
Formula:
C16H24O7
Formula Weight:
328.36
Specification
Target:
Endogenous metabolite
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -80°C.
Applications:
PGE-M plays a role in promoting gastrointestinal health and can be used in gastric and intestinal function research.
